Skip to main content
Figure 4 | Cancer Cell International

Figure 4

From: Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours

Figure 4

Albumin immunoreactivity. (A) Graph showing %DAB in albumin immunostained coronal sections of the brain at early, intermediate and late time points following internal carotid artery injection of CRCTU and ATCC Walker 256 tumour cells when compared to culture medium control brains; ***p<0.001. (B) Graph showing %DAB in albumin immunostained brain coronal sections 7 days and 4 weeks following CRCTU and ATCC Walker 256 tumour inoculation respectively, compared to culture medium control brains; ***p<0.001 (C) Coronal brain section stained for albumin 9 days following internal carotid artery injection of CRCTU Walker 256 breast carcinoma cells showing widespread immunoreactivity mainly in the right hemisphere. (D) Albumin immunostained brain coronal section 10 weeks post internal carotid artery injection with ATCC Walker 256 breast carcinoma cells showing peritumoral immunoreactivity.

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us